首页> 外国专利> TRANSGENIC DEMENTIA MICE EXPRESSING THE MUTAGENIC APP/C-105 GENE

TRANSGENIC DEMENTIA MICE EXPRESSING THE MUTAGENIC APP/C-105 GENE

机译:表达MUTAGENIC APP / C-105基因的转基因痴呆小鼠

摘要

invention APP/C-105 gene expression in transgenic Alzheimer mice on that, more specifically, - secretase APP gene as a Hydratase ( -secretase) is cut by enzymes of the human being consists of 56-63 amino acids and 42 amino acids in the neighboring carboxyl-terminal fragment of looking derived from APP / C-105-induced dementia genes and then NSE-specific gene promoter prepared by connecting a micro-fusion genes in the fertilized egg implanted in the brain of a mouse, this mouse embryos are implanted in the oviducts of surrogate relates to transgenic mice that produce dementia. ; Alzheimer transgenic mouse according to the present invention, as the expression of toxicity of the expressed protein and increase its binding proteins, such as human GSK3 and dementia of the Alzheimer's symptoms similar to brain dysfunction, and the amyloid -42 appears, a therapeutic agent of Alzheimer's disease or it can be used particularly useful in early diagnosis of Alzheimer's disease development.
机译:发明APP / C-105基因在转基因阿尔茨海默病小鼠中的表达,更具体地讲,-分泌酶APP基因作为水合酶(-分泌酶)被人体内由56-63个氨基酸和42个氨基酸组成的酶切割。从APP / C-105诱导的痴呆基因衍生出邻近的羧基末端片段,然后通过将微融合基因连接到植入小鼠脑中的受精卵中而制备出NSE特异性基因启动子,将这种小鼠胚胎植入替代物的输卵管中的“杀伤剂”涉及产生痴呆的转基因小鼠。 ;根据本发明的阿尔茨海默氏转基因小鼠,由于表达的蛋白表达毒性并增加其结合蛋白的表达,例如人GSK3和痴呆症的类似于大脑功能障碍的阿尔茨海默氏症的症状,而淀粉样蛋白-42的出现,是一种治疗阿尔茨海默氏病或​​其可用于阿尔茨海默氏病发展的早期诊断。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号